These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 31781351)

  • 21. Potential intervention target of atherosclerosis: Ferroptosis (Review).
    Li J; Xu L; Zuo YX; Chang XQ; Chi HT
    Mol Med Rep; 2022 Nov; 26(5):. PubMed ID: 36148885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment.
    Qiao O; Wang X; Wang Y; Li N; Gong Y
    J Adv Res; 2023 Dec; 54():211-222. PubMed ID: 36702249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane Damage during Ferroptosis Is Caused by Oxidation of Phospholipids Catalyzed by the Oxidoreductases POR and CYB5R1.
    Yan B; Ai Y; Sun Q; Ma Y; Cao Y; Wang J; Zhang Z; Wang X
    Mol Cell; 2021 Jan; 81(2):355-369.e10. PubMed ID: 33321093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferroptosis: past, present and future.
    Li J; Cao F; Yin HL; Huang ZJ; Lin ZT; Mao N; Sun B; Wang G
    Cell Death Dis; 2020 Feb; 11(2):88. PubMed ID: 32015325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis.
    Guo R; Duan J; Pan S; Cheng F; Qiao Y; Feng Q; Liu D; Liu Z
    Cell Death Dis; 2023 Jul; 14(7):426. PubMed ID: 37443140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress in Understanding Ferroptosis and Challenges in Its Targeting for Therapeutic Benefit.
    Zou Y; Schreiber SL
    Cell Chem Biol; 2020 Apr; 27(4):463-471. PubMed ID: 32302583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferroptosis and Necroptosis in the Kidney.
    Belavgeni A; Meyer C; Stumpf J; Hugo C; Linkermann A
    Cell Chem Biol; 2020 Apr; 27(4):448-462. PubMed ID: 32302582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferroptosis: A new insight for treatment of acute kidney injury.
    Li S; Wang R; Wang Y; Liu Y; Qiao Y; Li P; Chen J; Pan S; Feng Q; Liu Z; Liu D
    Front Pharmacol; 2022; 13():1065867. PubMed ID: 36467031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A tale of two lipids: Lipid unsaturation commands ferroptosis sensitivity.
    Rodencal J; Dixon SJ
    Proteomics; 2023 Mar; 23(6):e2100308. PubMed ID: 36398995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ferroptosis: A new mechanism of traditional Chinese medicine compounds for treating acute kidney injury.
    Shi Y; Shi X; Zhao M; Chang M; Ma S; Zhang Y
    Biomed Pharmacother; 2023 Jul; 163():114849. PubMed ID: 37172334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of nephric augmenter of liver regeneration facilitates acute kidney injury via ACSL4-mediated ferroptosis.
    Huang L; Zhang L; Zhang Z; Tan F; Ma Y; Zeng X; Cao D; Deng L; Liu Q; Sun H; Shen B; Liao X
    J Cell Mol Med; 2024 Feb; 28(3):e18076. PubMed ID: 38088220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ferroptosis as an emerging target in inflammatory diseases.
    Mao H; Zhao Y; Li H; Lei L
    Prog Biophys Mol Biol; 2020 Sep; 155():20-28. PubMed ID: 32311424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanisms of ferroptosis in the pathogenesis of kidney diseases.
    Liu J; Chen J; Lv J; Gong Y; Song J
    J Nephrol; 2024 May; 37(4):865-879. PubMed ID: 38704472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting ferroptosis as a vulnerability in pulmonary diseases.
    Yang L; Cao LM; Zhang XJ; Chu B
    Cell Death Dis; 2022 Jul; 13(7):649. PubMed ID: 35882850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SLC7A11-associated ferroptosis in acute injury diseases: mechanisms and strategies.
    Li P; Yu J; Huang F; Zhu YY; Chen DD; Zhang ZX; Xie ZC; Liu ZY; Hou Q; Xie N; Peng TH; Chen X; Li L; Xie W
    Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4386-4398. PubMed ID: 37259719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting ferroptosis by natural products in pathophysiological conditions.
    Zheng D; Jin S; Liu PS; Ye J; Xie X
    Arch Toxicol; 2024 Oct; 98(10):3191-3208. PubMed ID: 38987487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of ferroptosis in acute kidney injury: mechanisms and potential therapeutic targets.
    Yu Y; Zhang L; Zhang D; Dai Q; Hou M; Chen M; Gao F; Liu XL
    Mol Cell Biochem; 2024 Jun; ():. PubMed ID: 38943027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of GPX4 in ferroptosis and its pharmacological implication.
    Seibt TM; Proneth B; Conrad M
    Free Radic Biol Med; 2019 Mar; 133():144-152. PubMed ID: 30219704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging roles of ferroptosis in liver pathophysiology.
    Kim KM; Cho SS; Ki SH
    Arch Pharm Res; 2020 Oct; 43(10):985-996. PubMed ID: 33079307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Potential Therapeutic Targets of Ferroptosis in Skeletal Diseases.
    Liu X; Wang T; Wang W; Liang X; Mu Y; Xu Y; Bai J; Geng D
    Oxid Med Cell Longev; 2022; 2022():3112388. PubMed ID: 35941905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.